Screening identifies existing drugs as potential COVID-19 therapies
2021
The Scripps Research Institute, La Jolla, USA
The authors screened a drug repurposing library of over 12000 compounds against two high-throughput, high-content imaging infection assays with human cell lines to find possible COVID-19 drug candidates. They identified 90 existing drugs or drug candidates with antiviral activity against SARS-CoV-2. From these, four are clinically approved drugs and nine compounds are in other stages of development with strong potential to be repurposed as oral drugs for COVID-19.
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
Thomas F. Rogers, Malina A. Bakowski
Added on: 10-21-2021
[1] https://www.nature.com/articles/s41467-021-23328-0[2] https://www.drugtargetreview.com/news/92627/screening-identifies-existing-drugs-as-potential-covid-19-therapies/?utm_source=Email+marketing&utm_medium=email&utm_campaign=DTR+-+Industry+Insight+-+Beckman+Coulter+-+Screening+-+23.07.21&utm_term=Screening+identifies+existing+drugs+as+potential+COVID-19+therapies&utm_content=https%3a%2f%2femails.drugtargetreview.com%2frussellpublishinglz%2f&gator_td=m%2fDCNxHbm%2fskftaGYa66zO88WrJmwsmYAjoP5%2bb1UlkxkIRmyN%2blOPtNiTC%2fuMVase96%2fynTiT7vgNOgutaiW%2fxlXysDRrPCEklOg%2bf97D3e6BbfNgGl6MaBgSTTZNo3z%2fe2AWGt8Orny7DRpnzhaBVKzeIcmtoWopIUQvp7EbpB4iqL5KT%2fVWj311HHnxKsD%2bLelpcRj4wZuhXB05CDhGNnW2IpsmMsxN%2bqqwVDDdd2RC6srIiMhMNSGO3uIuFfUPAKu1rpvzBVwlfcJaMozw%3d%3d
